Bookmark and Share
mu-type opioid receptor isoform MOR-1 [Homo s.. [gi:117940060] - Target BioActivity Data
Also known as: mu-type opioid receptor isoform MOR-1 [Homo sapiens].
BioActivity Outcomes:
Active(2591)
 
 
Inactive(675635)
 
 
Unspecified(2)
 
 
BioAssay Types:
Screening(677193)
 
 
 
Confirmatory(1032)
 
 
 
BioActivity Types:
EC50(1007)
 
 
 
IC50(25)
 
 
 
Substance Types:
Chemical(678228)
 
 
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 19    Data Row: 678228   Total Pages: 13565   Display: Page     
Sort: [Click the result table header to sort]
#StructureSubstanceCompoundActivityBioAssayLinks
OutcomeTypeValue [μM]
1
[SID26670736]
[CID661788]
EC50 0.01406Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
2
[SID85273843]
[CID44246752]
EC50 0.01406Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
3
[SID56463128]
[CID16219954]
EC50 0.04226Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
4
[SID49672140]
[CID16288533]
EC50 0.04588Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
5
[SID93576955]
[CID4749]
EC50 0.12678Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
6
[SID24784258]
[CID16188374]
EC50 0.12678Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
7
[SID85273815]
[CID64761]
EC50 0.13204Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
8
[SID24800620]
[CID16192289]
EC50 0.15116Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
9
[SID49674907]
[CID16326480]
EC50 0.20015Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
10
[SID144241345]
[CID10407491]
EC50 0.206Late-stage results from the probe development effort to identify activators of OPRM1 and OPRD1 heterodimer formation: luminescence-based cell-based dose response assay, Set 2 [AID651762, Type: confirmatory]
View
11
[SID47197229]
[CID23723457]
EC50 0.22694Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
12
[SID17515694]
[CID3606260]
EC50 0.30341Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
13
[SID144087319]
[CID60156214]
IC50 0.323Late-stage results from the probe development effort to identify antagonists of OPRK1: luminescence-based cell-based dose response OPRM1 counterscreen [AID652034, Type: confirmatory]
View
14
[SID24832814]
[CID4391932]
EC50 0.37506Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
15
[SID51086057]
[CID24891945]
EC50 0.38052Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
16
[SID17515001]
[CID12005930]
EC50 0.38096Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
17
[SID144241350]
[CID25374006]
EC50 0.394Late-stage results from the probe development effort to identify activators of OPRM1 and OPRD1 heterodimer formation: luminescence-based cell-based dose response assay, Set 2 [AID651762, Type: confirmatory]
View
18
[SID134220670]
[CID23723457]
EC50 0.403Late-stage results from the probe development effort to identify activators of OPRM1 and OPRD1 heterodimer formation: luminescence-based cell-based dose response assay [AID651685, Type: confirmatory]
View
19
[SID24812061]
[CID5113104]
EC50 0.40787Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
20
[SID144087321]
[CID60156232]
IC50 0.479Late-stage results from the probe development effort to identify antagonists of OPRK1: luminescence-based cell-based dose response OPRM1 counterscreen [AID652034, Type: confirmatory]
View
21
[SID49672140]
[CID16288533]
EC50 0.5029Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization [AID588435, Type: confirmatory]
View
22
[SID24812451]
[CID5113106]
EC50 0.52401Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
23
[SID24798818]
[CID16190489]
EC50 0.53007Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
24
[SID24830029]
[CID3556099]
EC50 0.53473Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
25
[SID49679917]
[CID3432723]
EC50 0.55468Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
26
[SID144241343]
[CID16189614]
EC50 0.605Late-stage results from the probe development effort to identify activators of OPRM1 and OPRD1 heterodimer formation: luminescence-based cell-based dose response assay, Set 2 [AID651762, Type: confirmatory]
View
27
[SID24824323]
[CID16195712]
EC50 0.64012Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
28
[SID24799150]
[CID16190821]
EC50 0.65381Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
29
[SID85273815]
[CID64761]
EC50 0.78141Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization [AID588435, Type: confirmatory]
View
30
[SID51085872]
[CID24891919]
EC50 0.8556Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
31
[SID85147118]
[CID44142946]
EC50 0.89523Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
32
[SID24798818]
[CID16190489]
EC50 0.901Late-stage results from the probe development effort to identify activators of OPRM1 and OPRD1 heterodimer formation: luminescence-based cell-based dose response assay [AID651685, Type: confirmatory]
View
33
[SID49674927]
[CID4587627]
EC50 0.915Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
34
[SID14731391]
[CID1177949]
EC50 0.942Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
35
[SID85273813]
[CID9795678]
EC50 0.961Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
36
[SID85269391]
[CID16312302]
EC50 0.969Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
37
[SID47194324]
[CID44686]
EC50 0.982Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
38
[SID144087303]
[CID60156211]
IC50 1Late-stage results from the probe development effort to identify antagonists of OPRK1: luminescence-based cell-based dose response OPRM1 counterscreen [AID652034, Type: confirmatory]
View
39
[SID17514757]
[CID3600177]
EC50 1.024Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
40
[SID89851606]
[CID2999792]
EC50 1.063Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
41
[SID49677931]
[CID18574678]
EC50 1.254Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
42
[SID51086417]
[CID24892079]
EC50 1.272Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
43
[SID4242652]
[CID3237480]
EC50 1.274Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
44
[SID14742166]
[CID3799497]
EC50 1.38Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
45
[SID49674907]
[CID16326480]
EC50 1.42Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization [AID588435, Type: confirmatory]
View
46
[SID17409116]
[CID1233035]
EC50 1.53Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
47
[SID17514763]
[CID5113115]
EC50 1.539Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
48
[SID87347071]
[CID3799497]
EC50 1.63Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
49
[SID24783721]
[CID16188233]
EC50 1.671Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
50
[SID24798077]
[CID16189942]
EC50 1.749Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View